Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic

Abstract

Objective This study aims to assess the magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Addis Ababa, Ethiopia during the COVID-19 pandemic. Methods A multi-site cross-sectional design was conducted from 1st through 30th of August 2020 at public health facilities of the study area. Adult outpatients with T2DM and hypertension visiting hospitals and health centers were included in the study. A proportion to size allocation method was used to determine the required sample size per facility. Data was collected using the 8-item Morisky medication adherence scale. Descriptive statistics and binary logistic regression were used to analyze data. A 95% confidence interval and p≤0.05 statistical significance was considered to determine factors associated with poor medication adherence. Results A total of 409 patients were included in the present study. About 57% of the patients reported that the COVID-19 pandemic has posed negative impacts on either of their follow-up visits, availability of medications, or affordability of prices. And, 21% have reported that they have been affected in all aspects. The overall magnitude of poor medication adherence was 72%. Patients with extreme poverty were more likely to have good medication adherence (AOR: 0.59; 95%C.I: 0.36–0.97), whereas attendance to a health center (AOR: 1.71; 95%C.I: 1.02–2.85), presence of comorbidity (AOR: 2.05; 95%C.I: 1.13–3.71), and current substance use history (AOR: 11.57; 95%C.I: 1.52–88.05) predicted high odds of poor adherence. Conclusion Over a three-fourth of the patients, in the study setting, have poor adherence to their anti-diabetic and antihypertensive medications. Health facility type, income level, comorbidity, and current substance use history showed a statistically significant association with poor adherence to medication. Stakeholders should set alternative strategies as perceived impacts of the COVID-19 pandemic on medication adherence are high in the study area.

Factors Associated with Free Medicine Use in Patients with Hypertension and Diabetes: A 4-Year Longitudinal Study on Full Coverage Policy for Essential Medicines in Taizhou, China

“…In various settings, improved medicine accessibility through FCPEM programs proved to help reduce patients' direct medical costs and possibly lead to increased patient participation, continuity of treatment, and better health outcomes [15,[24][25][26][27]. Furthermore, we found that patients with characteristics indicative of free medicine use in our study coincided with patients who had chronic illnesses and poor medicine use and adherence in previous studies [28][29][30]. This implies that FCPEM implementation can promote equitable access to medicines and improve the health outcomes of vulnerable populations.…”

Quantifying the indirect impact of COVID-19 pandemic on utilisation of outpatient and immunisation services in Kenya: a longitudinal study using interrupted time series analysis

“…A survey in Ethiopia among diabetic and hypertensive patients reported unavailability, unaffordable or increased price of medications and interruptions in follow-up visits were common barriers to accessing chronic care units in public facilities during the pandemic. 65 Reduction in attendance for chronic conditions such as hypertensive cases is a significant finding as missing care for these chronic illnesses could lead to further complications and susceptibility to severe COVID-19, 66 and increased morbidity and mortality. The gradual decline Open access in HIV testing pre-COVID-19 might suggest reduced coverage due to policies geared towards targeted testing as opposed to blanket testing.…”

Socioeconomic Disparities in Hospital Utilization Among Female Workers in Indonesia: A Cross-Sectional Study

“… 40 , 41 In addition to that, several studies state that health insurance will increase the coverage of health services and improve the community’s health status. 23 , 38 , 42 , 43 …”